Journal Title：Current Cancer Drug Targets

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Cancer Drug Targets 旨在涵盖与癌症相关的当代分子药物靶点的药物化学、药理学、分子生物学、基因组学和生物化学的所有最新和杰出发展，例如疾病特异性蛋白质、受体、酶和基因。

Current Cancer Drug Targets 发表原创研究文章、信件、评论/小型评论、药物临床试验研究和客座编辑的主题问题，由该领域的领导者撰写，涵盖与癌症相关的药物靶点的一系列当前主题。

随着用于抗癌药物发现的新型人类药物靶点的发现、鉴定、表征和验证不断增长；该杂志已成为所有参与药物发现和开发的药物科学家的必备读物。